Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atholl Johnston

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Current Medical Research and Opinion|February 11, 2010
Challenges of therapeutic substitution of drugs for economic reasons: focus on CVD preventionAtholl Johnston
Therapeutic Drug Monitoring|January 18, 2012
The relevance of factor VIII (FVIII) pharmacokinetics to TDM and hemophilia a treatment: is B domain-deleted FVIII equivalent to full-length FVIII?Atholl Johnston
European Journal of Hospital Pharmacy : Science and Practice|October 4, 2013
Equivalence and interchangeability of narrow therapeutic index drugs in organ transplantationAtholl Johnston
British Journal of Clinical Pharmacology|November 18, 2003
The pharmacokinetics of voriconazoleAtholl Johnston
Expert Opinion on Investigational Drugs|April 19, 2005
Novel therapies in transplantationAnamaria Jorga, Atholl Johnston
Therapeutic Drug Monitoring|January 25, 2005
Seeking optimal prescription of cyclosporine MEMatthias Büchler, Atholl Johnston
Journal of Clinical Forensic Medicine|July 28, 2004
Re: Drugs, driving and sobriety testsAtholl Johnston, John Ramsey
Drug Testing and Analysis|December 12, 2013
Cannabis use: a perspective in relation to the proposed UK drug-driving legislationKim Wolff, Atholl Johnston
Transplantation|April 26, 2005
Risk factors for allograft failure in United kingdom renal transplant recipients treated with cyclosporine AXiang He, Atholl Johnston
Therapeutic Drug Monitoring|May 29, 2004
Monitoring immunosuppressive drugs: has it a future?David W Holt, Atholl Johnston
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Current Medical Research and Opinion|February 11, 2010
Challenges of therapeutic substitution of drugs for economic reasons: focus on CVD preventionAtholl Johnston
Therapeutic Drug Monitoring|January 18, 2012
The relevance of factor VIII (FVIII) pharmacokinetics to TDM and hemophilia a treatment: is B domain-deleted FVIII equivalent to full-length FVIII?Atholl Johnston
European Journal of Hospital Pharmacy : Science and Practice|October 4, 2013
Equivalence and interchangeability of narrow therapeutic index drugs in organ transplantationAtholl Johnston
British Journal of Clinical Pharmacology|November 18, 2003
The pharmacokinetics of voriconazoleAtholl Johnston
Expert Opinion on Investigational Drugs|April 19, 2005
Novel therapies in transplantationAnamaria Jorga, Atholl Johnston
Therapeutic Drug Monitoring|January 25, 2005
Seeking optimal prescription of cyclosporine MEMatthias Büchler, Atholl Johnston
Journal of Clinical Forensic Medicine|July 28, 2004
Re: Drugs, driving and sobriety testsAtholl Johnston, John Ramsey
Drug Testing and Analysis|December 12, 2013
Cannabis use: a perspective in relation to the proposed UK drug-driving legislationKim Wolff, Atholl Johnston
Transplantation|April 26, 2005
Risk factors for allograft failure in United kingdom renal transplant recipients treated with cyclosporine AXiang He, Atholl Johnston
Therapeutic Drug Monitoring|May 29, 2004
Monitoring immunosuppressive drugs: has it a future?David W Holt, Atholl Johnston
Pageof 10